185 related articles for article (PubMed ID: 7039836)
1. Suppression of natural tumor resistance by tumor promoters.
Keller R; Keist R; Köppel P; Hecker E
Carcinog Compr Surv; 1982; 7():643-5. PubMed ID: 7039836
[TBL] [Abstract][Full Text] [Related]
2. Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity.
Baxter CS; Fish LA; Ferguson TA; Michael JG; Bash JA
Carcinog Compr Surv; 1982; 7():637-42. PubMed ID: 6978182
[No Abstract] [Full Text] [Related]
3. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
Somers SD; Adams DO
J Immunol; 1986 Mar; 136(6):2323-32. PubMed ID: 3512713
[TBL] [Abstract][Full Text] [Related]
6. Prevention of interferon-induced augmentation of cellular antitumor effector mechanisms by phorbol esters.
Keller R; Aguet M; Tovey M; Stitz L
Cancer Res; 1982 Apr; 42(4):1468-72. PubMed ID: 6174224
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate.
Gemsa D; Staar U; Grimm W; Hausmann G; Körner CF; Resch K; Krammer PH
IARC Sci Publ; 1984; (56):319-36. PubMed ID: 6085623
[TBL] [Abstract][Full Text] [Related]
8. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
[TBL] [Abstract][Full Text] [Related]
9. [Studies on mouse macrophage activation. II. Dissociation of the suppressive effects of macrophages on lymphocytes vs tumor cells].
Sun DM; Shi W; Hu XZ; Lu S; Zhang YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):176-80. PubMed ID: 2939970
[No Abstract] [Full Text] [Related]
10. Effect of tumor promoters in immunological systems--the macrophage as a target cell for the action of phorbol esters.
Pick E; Keisari Y; Bromberg Y; Freund M; Yakubowski A
Carcinog Compr Surv; 1982; 7():625-35. PubMed ID: 6279302
[No Abstract] [Full Text] [Related]
11. Suppression of natural antitumour defence mechanisms by phorbol esters.
Keller R
Nature; 1979 Dec; 282(5740):729-31. PubMed ID: 514355
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol esters on alloimmune cytolysis.
Munger WE; Lindquist RR
Cancer Res; 1982 Dec; 42(12):5023-9. PubMed ID: 6814749
[TBL] [Abstract][Full Text] [Related]
13. Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
Ralph P; Williams N; Nakoinz I; Jackson H; Watson JD
J Immunol; 1982 Jul; 129(1):427-32. PubMed ID: 7045225
[No Abstract] [Full Text] [Related]
14. Effect of phorbol myristate acetate and a lymphokine on cyclic 3':5'-guanosine monophosphate levels and proliferation of macrophages.
Hadden EM; Sadlik JR; Coffey RG; Hadden JW
Cancer Res; 1982 Aug; 42(8):3064-9. PubMed ID: 6284356
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
16. Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
Kabelitz D; Kunkel HG
J Immunol; 1983 Jun; 130(6):2505-7. PubMed ID: 6189890
[TBL] [Abstract][Full Text] [Related]
17. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
Adams DO; Johnson WJ; Marino PA
Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes of natural antitumor resistance in spontaneously hypertensive rats with T-cell depression.
Matsuoka T; Takeichi N; Kobayashi H
Cancer Res; 1987 Jul; 47(13):3410-3. PubMed ID: 3495330
[TBL] [Abstract][Full Text] [Related]
20. [The resistance of in vivo selected tumor cells of malignant phenotype to the cytolytic action of activated peritoneal macrophages in vitro].
Vol'pe EA
Biull Eksp Biol Med; 1991 Feb; 111(2):177-9. PubMed ID: 1854964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
